Gatifloxacin sesquihydrate
CAS: 180200-66-2
Ref. 3D-FG40550
10g | A consultar | ||
25g | A consultar | ||
50g | A consultar | ||
100g | A consultar | ||
250g | A consultar |
Información del producto
- (±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, sesquihydrate
- 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methoxy-7-(3-Methyl-1-Piperazinyl)-4-Oxo-3-Quinolinecarboxylic Acid Monohydrate
- 1-Cyclopropyl-6-Fluoro-8-Methoxy-7-(3-Methylpiperazin-1-Yl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid Methanesulfonate (1:1)
- 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid sesquihydrate
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-, hydrate (2:3)
- Gatifloxacin Sesquihydrate
Gatifloxacin is an antibiotic that is active against a wide range of microorganisms, including gram-positive and gram-negative bacteria. It binds to the bacterial 16S ribosomal RNA and inhibits protein synthesis, leading to cell death by inhibiting the production of proteins vital for cell division. Gatifloxacin (GAT) has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex. Gatifloxacin sesquihydrate can be used in the treatment of infectious diseases caused by susceptible organisms. This drug also has a toxic effect on bowel disease cells, which may be due to its ability to induce apoptosis. Gatifloxacin sesquihydrate has been shown to inhibit mult
Propiedades químicas
Consulta técnica sobre: 3D-FG40550 Gatifloxacin sesquihydrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.